SAM
FENC icon

Smartleaf Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Smartleaf Asset Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$635 Hold
110
– – ﹤0.01% 3186
2025
Q4 		$854 Hold
110
– – ﹤0.01% 3182
2025
Q3 		$999 Hold
110
– – ﹤0.01% 2750
2025
Q2 		$907 Hold
110
– – ﹤0.01% 2493
2025
Q1 		$715 Hold
110
– – ﹤0.01% 2639
2024
Q4 		$677 Buy
+110
New +$563 ﹤0.01% 2736

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

Smartleaf Asset Management's FENC Position: Q1 2026 in Review

Smartleaf Asset Management held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 110 shares worth $635. The position accounts for ﹤0.01% of the portfolio, ranked #3186.

Smartleaf Asset Management first reported a position in FENC in Q4 2024 and has held it in 6 quarters since. The position peaked at $999 in Q3 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • Smartleaf Asset Management held 110 shares of Fennec Pharmaceuticals worth $635 as of Q1 2026.
  • Smartleaf Asset Management left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #3186 holding.
  • Smartleaf Asset Management first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Smartleaf Asset Management's Fennec Pharmaceuticals position peaked at $999 in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.